Thought Leadership
Regulating Advanced Therapies: Q&A with Patent Lawyer David Silverstein
August 26, 2020
Allie Nawrat
Pharmaceutical Technology

Axinn partner David Silverstein was featured in the Pharmaceutical Technology article, “Regulating Advanced Therapies: Q&A with Patent Lawyer David Silverstein.”

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.